Local and Systemic Alterations of the L-Arginine/Nitric Oxide Pathway in Sputum, Blood, and Urine of Pediatric Cystic Fibrosis Patients and Effects of Antibiotic Treatment
Alterations in the L-arginine (Arg)/nitric oxide (NO) pathway have been reported in cystic fibrosis (CF; OMIM 219700) as the result of various factors including systemic and local inflammatory activity in the airways. The aim of the present study was to evaluate the Arg/NO metabolism in pediatric CF...
Main Authors: | Beatrice Hanusch, Folke Brinkmann, Sebene Mayorandan, Kristine Chobanyan-Jürgens, Anna Wiemers, Kathrin Jansen, Manfred Ballmann, Anjona Schmidt-Choudhury, Alexander Bollenbach, Nico Derichs, Dimitrios Tsikas, Thomas Lücke |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/12/3802 |
Similar Items
-
Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New Results
by: Folke Brinkmann, et al.
Published: (2020-06-01) -
Characterization of the L-Arginine/Nitric Oxide Pathway and Oxidative Stress in Pediatric Patients with Atopic Diseases
by: Beatrice Hanusch, et al.
Published: (2022-02-01) -
Advanced Glycation End-Products (AGEs) of Lysine and Effects of Anti-TCR/Anti-TNF-α Antibody-Based Therapy in the LEW.1AR1<i>-iddm</i> Rat, an Animal Model of Human Type 1 Diabetes
by: Svetlana Baskal, et al.
Published: (2022-01-01) -
Transport and storage of sputum specimen by using cetylpyridinium chloride for isolation of mycobacteria
by: Pal Nita, et al.
Published: (2009-01-01) -
Type III Secretion Effectors with Arginine N-Glycosyltransferase Activity
by: Juan Luis Araujo-Garrido, et al.
Published: (2020-03-01)